Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED)

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)981-983
Number of pages3
JournalActa Diabetologica
Volume55
Issue number9
DOIs
Publication statusPublished - Sep 2018

Cite this

Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED) (2018). Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing? Acta Diabetologica, 55(9), 981-983. https://doi.org/10.1007/s00592-018-1179-y

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing? / Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED).

In: Acta Diabetologica, Vol. 55, No. 9, 09.2018, p. 981-983.

Research output: Contribution to journalArticle

Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED) 2018, 'Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?', Acta Diabetologica, vol. 55, no. 9, pp. 981-983. https://doi.org/10.1007/s00592-018-1179-y
Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED). Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing? Acta Diabetologica. 2018 Sep;55(9):981-983. https://doi.org/10.1007/s00592-018-1179-y
Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED). / Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?. In: Acta Diabetologica. 2018 ; Vol. 55, No. 9. pp. 981-983.
@article{a0597cb533c74f71a46e7f952c3a6aa5,
title = "Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?",
author = "{Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED)} and Maurizio Delvecchio and Giuseppina Salzano and Clara Bonura and Vittoria Cauvin and Valentino Cherubini and Giuseppe d'Annunzio and Adriana Franzese and Sabrina Giglio and Valeria Grasso and Vanna Graziani and Dario Iafusco and Lorenzo Iughetti and Riccardo Lera and Claudio Maffeis and Giulio Maltoni and Vilma Mantovani and Claudia Menzaghi and Patera, {Patrizia I} and Ivana Rabbone and Petra Reindstadler and Sabrina Scelfo and Nadia Tinto and Sonia Toni and Stefano Tumini and Fortunato Lombardo and Antonio Nicolucci and Fabrizio Barbetti",
year = "2018",
month = "9",
doi = "10.1007/s00592-018-1179-y",
language = "English",
volume = "55",
pages = "981--983",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "9",

}

TY - JOUR

T1 - Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing?

AU - Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetes (ISPED)

AU - Delvecchio, Maurizio

AU - Salzano, Giuseppina

AU - Bonura, Clara

AU - Cauvin, Vittoria

AU - Cherubini, Valentino

AU - d'Annunzio, Giuseppe

AU - Franzese, Adriana

AU - Giglio, Sabrina

AU - Grasso, Valeria

AU - Graziani, Vanna

AU - Iafusco, Dario

AU - Iughetti, Lorenzo

AU - Lera, Riccardo

AU - Maffeis, Claudio

AU - Maltoni, Giulio

AU - Mantovani, Vilma

AU - Menzaghi, Claudia

AU - Patera, Patrizia I

AU - Rabbone, Ivana

AU - Reindstadler, Petra

AU - Scelfo, Sabrina

AU - Tinto, Nadia

AU - Toni, Sonia

AU - Tumini, Stefano

AU - Lombardo, Fortunato

AU - Nicolucci, Antonio

AU - Barbetti, Fabrizio

PY - 2018/9

Y1 - 2018/9

U2 - 10.1007/s00592-018-1179-y

DO - 10.1007/s00592-018-1179-y

M3 - Article

VL - 55

SP - 981

EP - 983

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 9

ER -